Treatment Patterns and Clinical Outcomes in Patients with Egfr-Mutated Non-Small Cell Lung Cancer after Progression on Osimertinib
CLINICAL LUNG CANCER（2025）
Key words
NSCLC,Acquired resistance,Targeted therapy,Non-small cell lung cancer,Chemotherapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined